Broadcast Date: November 25, 2025
Speakers: Drs. David Bewick, Sean Virani, Shelley Zieroth, Natasha Aleksova, Kim Anderson, Michael McDonald, Eileen O'Meara, and Stephanie Poon
By the end of this webinar, participants will be able to:
- Integrate updated CCS/CHFS guideline recommendations for managing heart failure with mildly reduced and preserved ejection fraction using pharmacologic therapies
- Identify patient subgroups likely to benefit from specific drug classes
- Apply treatment strategies based on comorbidities and patient-specific factors to optimize heart failure outcomes
- Discuss key concepts contained in the CCS/CHFS 2025 Guideline Update for Pharmacologic Management of Heart Failure with Non Reduced Ejection Fraction (LVEF > 40%) to promote and facilitate guideline-based care in clinical practice